跳到主要內容
big screen image small screen image
Font Size
A
A
A
轉寄 轉寄
(Exclusive License) Technology Transfer Enterprise Selection Announcement - Smart AI Pharmaceutical of the New Era: Fast Screening Platform for New Usage of Existing Drugs and the First-ever Drug License
Date of Announcement
2020-10-12

Subject

(Exclusive License) Technology Transfer Enterprise Selection Announcement - Smart AI Pharmaceutical of the New Era: Fast Screening Platform for New Usage of Existing Drugs and the First-ever Drug License

Content

  • Technology:

Smart AI Pharmaceutical of the New Era: Fast Screening Platform for New Usage of Existing Drugs and the First-ever Drug License

  • Provider:

Professor Jian-jhang Li  

  • Enterprise Eligibility

1. Industry Category: Biotechnology and medicine

2. Required Technical Know-how: Clinical medicine, epidemiology, pharmacology, and strategic IP deployment

3. Required Machinery and Equipment: No specific restrictions

4. Required Research or Technical Staff: Clinical medicine, epidemiology, pharmacology, and strategic IP deployment

5. Other Requirements: No specific restrictions

 

The university's regulations relevant to technology transfer shall be complied with for matters not aforementioned.

 

  • How to apply? Please go to the Center of Industry-Academia Collaboration of the Office of Research and Development to inquire about relevant information.

Contact Person

Alex Kao

TEL: +886-2-33669988

Email: cmkao@ntu.edu.tw

File download:
Technology Transfer Enterprise Selection Announcement-Prophylatic Use of Calcium Channel Blocker in Tuberculosis
File size: 340kb